Companies / M7T

MACH7 TECHNOLOGIES LIMITED

ASX:M7THealth Care Equipment & Services
235.0M shares on issueASX (delayed) · as of 28 July 2026$0.29price · delayed$69.3Mmarket cap · indicative
A
Dilution grade

No major dilution pressure signals in current disclosures

Cash runway134.9 quarters of funding
Share-count growth (24m)-2.6%
Raise cadence (24m)0 cash raises
Options & rights overhang4.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

MACH7 TECHNOLOGIES LIMITED's ordinary share count declined 2.6% between January 2024 and January 2026, standing at 235M shares as of January 2026. The company did not raise capital in the 24-month window. Options and rights on issue could convert into 10M new shares, equal to 4.1% of the current share count, with the nearest expiry in August 2026 and 0% of current shares in the money. At the March 2026 quarter the company reported A$20.6M in available cash, which it states covers 134.9 quarters at its recent spending rate. There are no proposed securities issues (Appendix 3B) pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
4.1%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
134.9 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 235.0M per ASX (delayed) (28 July 2026).
236.3M238.1M239.9MDec 24Sept 25July 26

Cash runway

Cover not computed for the latest quarter.
$20.6M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
11 June 20263H · cancellationM7T : ORDINARY FULLY PAID235.0MAppendix 3H
5 June 20263G · unquotedM7T : ORDINARY FULLY PAID235.0MAppendix 3G
17 May 20263H · cancellationM7T : ORDINARY FULLY PAID235.0MAppendix 3H
30 Mar 20263H · cancellationM7T : ORDINARY FULLY PAID235.0MAppendix 3H
10 Mar 20263H · cancellationM7T : ORDINARY FULLY PAID235.0MAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

4.1%
Total overhang · of current shares
0.0%
In the money · at current price
9.6M
Potential new shares
Aug 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
20 May 2026Teri Jo ThomasBuy200k$64k3Y notice
31 Mar 2026Teri Jo ThomasBuy50k$14k3Y notice
30 Mar 2026Robert BazzaniBuy19k$03Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.